Nilgün Yılmaz Demirci

Dr. Nilgün Yılmaz Demirci

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2010 in World Journal of Gastroenterology
Verified
Journal Article
Open access
AYAydın Yılmaz
Aydın Yılmaz
NDNilgün Yılmaz Demirci
Nilgün Yılmaz Demirci
DHDerya Hoşgün
Derya Hoşgün
EÜEnver Üner
Enver Üner
YEYurdanur Erdoğan
Yurdanur Erdoğan
AÇAtalay Çağlar
Atalay Çağlar
AIM: To determine the relationship of pulmonary abnormalities and bowel disease activity in inflammatory bowel disease (IBD).

18 October 2018 in Turkish Thoracic Journal
Verified
Journal Article
Closed access
ABAyse Baha
Ayse Baha
FYFatma Yildirim
Fatma Yildirim
NKNurdan Kokturk
Nurdan Kokturk
ZGZuleyha Galata
Zuleyha Galata
NANalan Akyurek
Nalan Akyurek
HTHaluk Türktaş3
Haluk Türktaş3
Turkthoracj, Turkish Thoracic Journal

3 February 2013 in Virchows Archiv
Verified
Journal Article
Closed access
PDF file
IAİbRahim Onur Alici
İbRahim Onur Alici
NDNilgün Yılmaz Demirci
Nilgün Yılmaz Demirci
AYAydın Yılmaz
Aydın Yılmaz
FDFunda Demirag
Funda Demirag
JKJale Karakaya
Jale Karakaya

3 March 2015 in The Clinical Respiratory Journal
Verified
Journal Article
Closed access
PDF file
IAIbrahim Onur Alici
Ibrahim Onur Alici
NDNilgün Yılmaz Demirci
Nilgün Yılmaz Demirci
AYAydın Yılmaz
Aydın Yılmaz
JKJale Karakaya
Jale Karakaya
EÖEsra Özaydın
Esra Özaydın

29 January 2014 in Journal of Cancer Research and Clinical Oncology
Verified
Journal Article
Closed access
PDF file
SUSukran Ulger
Sukran Ulger
NDNilgün Yılmaz Demirci
Nilgün Yılmaz Demirci
FEFatma Nazan Eroglu
Fatma Nazan Eroglu
HCHuriye Hulya Cengiz
Huriye Hulya Cengiz
MTMustafa Tunc
Mustafa Tunc
MCMustafa Cengiz
Mustafa Cengiz

9 December 2014 in Respiratory Care
Verified
Journal Article
Open access
HSHilal Sazak
Hilal Sazak
MTMehtap Tunç
Mehtap Tunç
AAAli Alagoz
Ali Alagoz
PPPolat Pehlivanoğlu
Polat Pehlivanoğlu
NDNilgün Yılmaz Demirci
Nilgün Yılmaz Demirci
AYAydın Yılmaz
Aydın Yılmaz
BACKGROUND: Transbronchial needle aspiration using endobronchial ultrasonography (EBUS-TBNA), a new minimally invasive diagnostic procedure, has been used to evaluate intrathoracic lymph nodes. It has been reported that EBUS-TBNA can be performed safely under sedation and provides a high level of patient satisfaction. We aimed to describe perianesthetic data, and compare results regarding the agents of subjects undergoing EBUS-TBNA under deep sedation. METHODS: After ethics committee approval, perianesthetic data of 571 subjects undergoing EBUS-TBNA were analyzed retrospectively. Data were collected from anesthesia evaluation and observation forms. Four groups received anesthesia in the operating room as follows: propofol-midazolam (group PM), propofol-ketamine (group PK), propofol-ketamine-midazolam (group PKM), or propofol (group P). Dosage, number of anesthetic injection, hemodynamic variables, recovery time, complications, and patient satisfaction were also recorded. RESULTS: Propofol consumption was higher in groups P and PM compared with groups PK and PKM. Midazolam requirement was higher in group PM than in group PKM. Recovery time was shorter in group P compared with groups PK, PM, and PKM. It was also shorter in groups PK and PM compared with group PKM. All of these differences were statistically significant. Temporary desaturation ( n = 41; 7%) and increased blood pressure (n = 78; 14%) were predominant complications. In groups PK and PKM, risk of developing hypertension was higher than in groups PM and P ( P < .001). The percentage of subjects satisfied with the procedure was 99%. CONCLUSIONS: Independent from the sedative agent, deep sedation can be safe, and provide high patient satisfaction during EBUS-TBNA. The combination of ketamine with propofol or midazolam required lower doses of these anesthetics. However, the incidence of increased blood pressure was higher in groups administered ketamine. Recovery time was the shortest in group P, and the longest in group PKM. There was no relation between recovery time and total dose of anesthetics or presence of chronic disease.